Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(86)
Filter by content year
(-)
2023
(86)
Filter by form group
Filter by category
(-)
All
(86)
Collaborators
(30)
Other
(30)
Financial
(24)
Events
(18)
Clinical
(14)
Science
(12)
HR
(2)
Filter by category
Search
News
BioNTech Completes Acquisition of InstaDeep
News
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
News
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
News
BioNTech erweitert Vorstand mit James Ryan als Chief Legal Officer
News
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
News
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron XBB.1.5 angepassten COVID-19-Impfstoff in der Europäischen Union
News
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
News
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
News
BioNTech und CEPI geben Partnerschaft zur Entwicklung eines mRNA-Mpox-Impfstoffs und zur Unterstützung von CEPIs 100-Tage-Ziel bekannt
News
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
Pagination
Previous page
‹‹
Page 2
Next page
››